In hypercholesterolemia, adding inclisiran to individually optimized lipid-lowering therapy improved LDL-C levels at 90 d. Allan T, Newby LK. Ann Intern Med 2026 Jan 6. doi: 10.7326/ANNALS-25-05115.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Allan T, Newby LK. In hypercholesterolemia, adding inclisiran to individually optimized lipid-lowering therapy improved LDL-C levels at 90 d. Ann Intern Med 2026 Jan 6. doi: 10.7326/ANNALS-25-05115.
PMID: 41490496